CONMED Corporation provided financial guidance for the full year 2024. The Company expects full-year 2024 reported revenue between $1.340 billion and $1.365 billion. This represents year-over-year growth of approximately 8% to 10%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.52 USD | +0.61% | -0.45% | -31.95% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.95% | 2.28B | |
-7.38% | 181B | |
-0.46% | 108B | |
-6.98% | 66.12B | |
+2.65% | 50.65B | |
+5.27% | 43.11B | |
+6.30% | 40.74B | |
+19.92% | 31.6B | |
+16.12% | 25.56B | |
-7.00% | 24.16B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Provides Financial Guidance for the Full Year 2024